[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Kuttner-Kondo et al., 1996 - Google Patents

Molecular modeling and mechanism of action of human decay-accelerating factor

Kuttner-Kondo et al., 1996

View PDF
Document ID
7602879003825950188
Author
Kuttner-Kondo L
Medof M
Brodbeck W
Shoham M
Publication year
Publication venue
Protein Engineering, Design and Selection

External Links

Snippet

A model of the regulatory region of human decay accelerating factor (DAF) was built based on the known coordinates of a fragment of the structurally and functionally homologous serum protein, factor H. According to this model, the four short consensus repeats (SCRs) in …
Continue reading at academic.oup.com (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/472—Complement proteins, e.g. anaphylatoxin, C3a, C5a
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/7056—Lectin superfamily, e.g. CD23, CD72
    • C07K14/70564—Selectins, e.g. CD62
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2299/00—Coordinates from 3D structures of peptides, e.g. proteins or enzymes

Similar Documents

Publication Publication Date Title
Kuttner-Kondo et al. Molecular modeling and mechanism of action of human decay-accelerating factor
EP2569332B1 (en) Improved complement receptor 2 (cr2) targeting groups
Jokiranta et al. Nephritogenic λ light chain dimer: a unique human miniautoantibody against complement factor H
Zhang et al. Sequence‐specific recognition of the internalization motif of the Alzheimer's amyloid precursor protein by the X11 PTB domain
Clemenza et al. Structure-guided identification of C3d residues essential for its binding to complement receptor 2 (CD21)
AU8472298A (en) Bactericidal/permeability-increasing protein: crystallization, x-ray diffraction, three-dimensional structure determination, rational drug design and molecular modeling of related proteins
Lambris et al. Third component of trout complement. cDNA cloning and conservation of functional sites.
KR20180091097A (en) Polypeptides for inhibiting complement activation
US7214772B2 (en) Sialoadhesin family member-2 (SAF-2)
Iwahara et al. A helix–turn–helix structure unit in human centromere protein B (CENP‐B)
EP1003780A1 (en) Human f11 antigen: a cell surface receptor involved in platelet aggregation
Guillon et al. A staggered decameric assembly of human C-reactive protein stabilized by zinc ions revealed by X-ray crystallography
Krishnan et al. The crystal structure of cobra venom factor, a cofactor for C3-and C5-convertase CVFBb
Merlino et al. Chain termini cross-talk in the swapping process of bovine pancreatic ribonuclease
EP1100822A1 (en) Secreted cysteine rich protein-6 (scrp-6)
CA2565227A1 (en) Human complement c3 derivates with cobra venom factor-like function
Morgan et al. Crystallographic determination of the disease-associated T1184R variant of complement regulator factor H
EP3424957A1 (en) Fusion protein
JPH1142093A (en) Sialoadhesin family member-3
US7547676B2 (en) Antagonist peptides to the C5A chemotactic function of vitamin D binding protein
US6200776B1 (en) Polynucleotides encoding human sodium bicarbonate cotransporters
HK1176359B (en) Improved complement receptor 2 (cr2) targeting groups
HK1176359A (en) Improved complement receptor 2 (cr2) targeting groups
JP2002521018A (en) Scrp-5: secreted cysteine-rich protein-5
Shiltagh Solution structure of the factor VIII binding region on von Willebrand factor